Prevalence of the Prescription of Potentially Interacting Drugs

The use of multiple medications is becoming more common, with a correspondingly increased risk of untoward effects and drug-related morbidity and mortality. We aimed at estimating the prevalence of prescription of relevant potentially interacting drugs and at evaluating possible predictors of potentially interacting drug exposure. We retrospectively analyzed data on prescriptions dispensed from January 2004 to August 2005 to individuals of two Italian regions with a population of almost 2.1 million individuals. We identified 27 pairs of potentially interacting drugs by examining clinical relevance, documentation, and volume of use in Italy. Subjects who received at least one prescription of both drugs were selected. Co-prescribing denotes “two prescriptions in the same day”, and concomitant medication “the prescription of two drugs with overlapping coverage”. A logistic regression analysis was conducted to examine the predictors of potential Drug-Drug Interaction (pDDIs). 957,553 subjects (45.3% of study population) were exposed to at least one of the drugs/classes of the 27 pairs. Overall, pDDIs occurred 2,465,819 times. The highest rates of concomitant prescription and of co-prescription were for ACE inhibitors+NSAIDs (6,253 and 4,621/100,000 plan participants). Considering concomitance, the male/female ratio was <1 in 17/27 pairs (from 0.31 for NSAIDs-ASA+SSRI to 0.74 for omeprazole+clopidogrel). The mean age was lowest for methotrexate pairs (+omeprazole, 59.9 years; +NSAIDs-ASA, 59.1 years) and highest for digoxin+verapamil (75.4 years). In 13/27 pairs, the mean ages were ≥70 years. On average, subjects involved in pDDIs received ≥10 drugs. The odds of exposure were more frequently higher for age ≥65 years, males, and those taking a large number of drugs. A substantial number of clinically important pDDIs were observed, particularly among warfarin users. Awareness of the most prevalent pDDIs could help practitioners in preventing concomitant use, resulting in a better quality of drug prescription and potentially avoiding unwanted side effects.

[1]  Marlene R. Miller,et al.  Suboptimal Prescribing in Elderly Outpatients: Potentially Harmful Drug‐Drug and Drug‐Disease Combinations , 2005, Journal of the American Geriatrics Society.

[2]  R. Leone,et al.  Identification of severe potential drug-drug interactions using an Italian general-practitioner database , 2008, European Journal of Clinical Pharmacology.

[3]  A. Egberts,et al.  Frequency and nature of drug-drug interactions in a Dutch university hospital. , 2009, British journal of clinical pharmacology.

[4]  S. Speedie,et al.  Detecting Drug Interactions: A Review of the Literature , 1990, DICP : the annals of pharmacotherapy.

[5]  M. Oertle.  Frequency and nature of drug-drug interactions in a Swiss primary and secondary acute care hospital. , 2012, Swiss medical weekly.

[6]  H. Tobi,et al.  Studying co‐medication patterns: the impact of definitions , 2007, Pharmacoepidemiology and drug safety.

[7]  R. Hatton,et al.  Evaluation of Contraindicated Drug-Drug Interaction Alerts in a Hospital Setting , 2011, The Annals of pharmacotherapy.

[8]  Diane L. Seger,et al.  Application of Information Technology: Improving Acceptance of Computerized Prescribing Alerts in Ambulatory Care , 2006, J. Am. Medical Informatics Assoc..

[9]  A. Grizzle,et al.  Drug-related morbidity and mortality: updating the cost-of-illness model. , 2001, Journal of the American Pharmaceutical Association.

[10]  P. Moore,et al.  Adverse drug interactions involving common prescription and over-the-counter analgesic agents. , 2007, Clinical therapeutics.

[11]  A. Laupacis,et al.  Drug-drug interactions among elderly patients hospitalized for drug toxicity. , 2003, JAMA.

[12]  J. Oates.  Antagonism of Antihypertensive Drug Therapy by Nonsteroidal Anti‐Inflammatory Drugs , 1988, Hypertension.

[13]  J. Brouwers,et al.  Clinical Relevance of Drug-Drug Interactions , 2005, Drug safety.

[14]  M. Pelagatti,et al.  ASSET (Age/Sex Standardised Estimates of Treatment): A Research Model to Improve the Governance of Prescribing Funds in Italy , 2007, PloS one.

[15]  S. Karas,et al.  The potential for drug interactions. , 1981, Annals of emergency medicine.

[16]  V. Maio,et al.  Prevalence and predictors of potential drug–drug interactions in Regione Emilia‐Romagna, Italy , 2008, Journal of clinical pharmacy and therapeutics.

[17]  Daniel C Malone,et al.  Prescribers’ Knowledge of and Sources of Information for Potential Drug-Drug Interactions , 2008, Drug safety.

[18]  Anthony J Avery,et al.  Incidence and Possible Causes of Prescribing Potentially Hazardous/Contraindicated Drug Combinations in General Practice , 2005, Drug safety.

[19]  S. Preskorn,et al.  The economic consequences of a drug-drug interaction. , 2001, Journal of clinical psychopharmacology.

[20]  S. Janković,et al.  Prevalence and predictors of potential drug-drug interactions , 2014 .

[21]  R. Lipton,et al.  Assessment of potential drug-drug interactions with a prescription claims database. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[22]  B. Stricker,et al.  Hospitalisations and emergency department visits due to drug–drug interactions: a literature review , 2007, Pharmacoepidemiology and drug safety.

[23]  Göran Petersson,et al.  Detection of potential drug interactions – a model for a national pharmacy register , 2006, European Journal of Clinical Pharmacology.

[24]  A. Mehlhorn,et al.  Infectious Diseases: Safety Concerns with Fluoroquinolones , 2007, The Annals of pharmacotherapy.

[25]  J. Visconti,et al.  An epidemiological study of the clinical significance of drug-drug interactions in a private community hospital. , 1971, American journal of hospital pharmacy.

[26]  M. Afilalo,et al.  Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. , 2001, Annals of emergency medicine.

[27]  Roger B. Davis,et al.  Clinicians' assessments of electronic medication safety alerts in ambulatory care. , 2009, Archives of internal medicine.

[28]  Morten Andersen,et al.  Exposure to potential drug interactions in primary health care , 2003, Scandinavian journal of primary health care.

[29]  R. Lipton,et al.  Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. , 2005, Journal of the American Pharmacists Association : JAPhA.

[30]  Social contexts of sports-practicing youths' hazardous drinking. , 2012, Swiss medical weekly.

[31]  W P McKinney,et al.  Pharmacist recognition of potential drug interactions. , 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[32]  Z. Rumboldt,et al.  Interaction between antihypertensives and NSAIDs in primary care: a controlled trial. , 2008, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[33]  C. A. Jankel,et al.  Epidemiology of Drug-Drug Interactions as a Cause of Hospital Admissions , 1993, Drug safety.

[34]  Todd D. Sorensen,et al.  A pharmacy course on leadership and leading change. , 2009, American journal of pharmaceutical education.

[35]  Tom Schalekamp,et al.  Potential Determinants of Drug-Drug Interaction Associated Dispensing in Community Pharmacies , 2005, Drug safety.

[36]  J. M. Cruciol-Souza,et al.  Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[37]  R. Riechelmann,et al.  Adverse drug reactions and drug interactions as causes of hospital admission in oncology. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  F Y Aoki,et al.  Drug‐Associated Hospital Admissions in Older Medical Patients , 1988, Journal of the American Geriatrics Society.

[39]  P. McDonnell,et al.  Hospital Admissions Resulting from Preventable Adverse Drug Reactions , 2002, The Annals of pharmacotherapy.

[40]  John E. Murphy,et al.  Medical, nursing, and pharmacy students’ ability to recognize potential drug–drug interactions: A comparison of healthcare professional students , 2011, Journal of the American Academy of Nurse Practitioners.

[41]  P. Glassman,et al.  Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population. , 2003, Journal of managed care pharmacy : JMCP.

[42]  J. Deligne,et al.  Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999 , 2003, European Journal of Clinical Pharmacology.

[43]  E. Autret‐Leca,et al.  Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study , 2005, European Journal of Clinical Pharmacology.

[44]  Amy J Grizzle,et al.  Pharmacist Workload and Pharmacy Characteristics Associated With the Dispensing of Potentially Clinically Important Drug-Drug Interactions , 2007, Medical care.

[45]  B. González López-Valcárcel,et al.  Risk factors for potential drug interactions in general practice , 2008, The European journal of general practice.

[46]  P. Glassman,et al.  Improving Recognition of Drug Interactions: Benefits and Barriers to Using Automated Drug Alerts , 2002, Medical care.

[47]  M. Langdorf,et al.  Physician versus computer knowledge of potential drug interactions in the emergency department. , 2000, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[48]  R. Woosley,et al.  Pharmacies and prevention of potentially fatal drug interactions. , 1996, JAMA.